Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
The D2 dopamine receptor (DRD2) is one of the most well-established therapeutic targets for neuropsychiatric and endocrine disorders. Here, the authors report the crystal structure of the antipsychotic drug haloperidol bound to DRD2 via an extended binding pocket that distinguishes it from other D2-...
Main Authors: | Luyu Fan, Liang Tan, Zhangcheng Chen, Jianzhong Qi, Fen Nie, Zhipu Luo, Jianjun Cheng, Sheng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-14884-y |
Similar Items
-
Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870
by: Ye Zhou, et al.
Published: (2019-11-01) -
Haloperidol effects on striatal dopamine and DOPAC levels and subcellular distribution
by: Wallace Lane J
Published: (2012-07-01) -
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
by: Jean Claude Martel, et al.
Published: (2020-07-01) -
Parkinson’s Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response
by: Craig J. Hudson, et al.
Published: (2014-01-01) -
Haloperidol interferes with the impact of rewarding and aversive stimuli: Re-appraisal of the anhedonia hypothesis of dopamine blocking
by: Andrew Chih Wei Huang, et al.
Published: (2003)